Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Farmers Insurance
Chubb
Fuji
Argus Health
Cantor Fitzgerald
Colorcon
McKesson
Moodys
Chinese Patent Office

Generated: February 21, 2018

DrugPatentWatch Database Preview

Tavaborole - Generic Drug Details

« Back to Dashboard

What are the generic sources for tavaborole and what is the scope of tavaborole patent protection?

Tavaborole
is the generic ingredient in one branded drug marketed by Anacor Pharms Inc and is included in one NDA. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Tavaborole has sixty-seven patent family members in twenty countries.

There are three drug master file entries for tavaborole. One supplier is listed for this compound.
Summary for tavaborole
International Patents:67
US Patents:5
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 3
Suppliers / Packagers: 1
Bulk Api Vendors: 46
Patent Applications: 68
Drug Prices:see low prices
DailyMed Link:tavaborole at DailyMed
Pharmacology for tavaborole
Ingredient-typeBoron Compounds
Drug ClassOxaborole Antifungal
Mechanism of ActionProtein Synthesis Inhibitors

US Patents and Regulatory Information for tavaborole

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Anacor Pharms Inc KERYDIN tavaborole SOLUTION;TOPICAL 204427-001 Jul 7, 2014 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Anacor Pharms Inc KERYDIN tavaborole SOLUTION;TOPICAL 204427-001 Jul 7, 2014 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Anacor Pharms Inc KERYDIN tavaborole SOLUTION;TOPICAL 204427-001 Jul 7, 2014 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Anacor Pharms Inc KERYDIN tavaborole SOLUTION;TOPICAL 204427-001 Jul 7, 2014 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Anacor Pharms Inc KERYDIN tavaborole SOLUTION;TOPICAL 204427-001 Jul 7, 2014 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Anacor Pharms Inc KERYDIN tavaborole SOLUTION;TOPICAL 204427-001 Jul 7, 2014 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for tavaborole

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,767,657 Boron-containing small molecules ➤ Sign Up
8,440,642 Boron-containing small molecules ➤ Sign Up
8,722,917 Boron-containing small molecules ➤ Sign Up
9,353,133 Boron-containing small molecules ➤ Sign Up
8,889,656 Boron-containing small molecules ➤ Sign Up
8,039,451 Boron-containing small molecules ➤ Sign Up
8,115,026 Boron-containing small molecules ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for tavaborole

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Citi
Express Scripts
Cipla
Baxter
Chinese Patent Office
US Army
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot